Combined Modality Radioimmunotherapy with Taxol and ⁹⁰Y-LYM-1 for Raji Lymphoma Xenografts

Bcl-2 and the regulation of programmed cell death

1994 • 2,346 citations

Cancer statistics, 1997

1997 • 2,045 citations

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

1982 • 1,424 citations

Adjuvant Therapy for Patients With Colon and Rectal Cancer

1990 • 1,047 citations

Clinical toxicities encountered with paclitaxel (Taxol).

1993 • 682 citations

Structure and Function of the p53 Tumor Suppressor Gene: Clues for Rational Cancer Therapeutic Strategies

1996 • 666 citations

Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.

1996 • 662 citations

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1996 • 654 citations

Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody

1993 • 557 citations

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

1995 • 447 citations

Treatment of Non-Hodgkin's Lymphoma

1993 • 387 citations

Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma

1997 • 281 citations

Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer

1996 • 271 citations

Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.

1990 • 151 citations

Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.

1987 • 149 citations

Treatment of cancer with radiation and drugs.

1996 • 138 citations

Cancer Therapy with Radiolabeled Antibodies

2018 • 115 citations

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts

1997 • 112 citations

Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.

1995 • 104 citations

Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.

1995 • 101 citations

Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice.

1988 • 100 citations

Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.

1992 • 89 citations

Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial.

1997 • 83 citations

Increased survival associated with radiolabeled lym-1 therapy for non-hodgkin's lymphoma and chronic lymphocytic leukemia

1997 • 65 citations

Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.

1997 • 62 citations

Comparative toxicity studies of yttrium-90 mx-dtpa and 2-it-bad conjugated monoclonal antibody (bre-3)

1994 • 59 citations

p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas.

1992 • 55 citations

Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).

1997 • 45 citations

Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing mice.

1995 • 42 citations

Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies

1993 • 37 citations

Radioimmunotherapy of Lymphoma: A UC Davis Experience

1995 • 34 citations

Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies.

1997 • 28 citations

p53 Expression in Non-Hodgkin's Lymphomas: A Marker of p53 Inactivation?

1995 • 27 citations

Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.

1996 • 19 citations

Paclitaxel-containing high-dose chemotherapy: the University of Colorado experience.

1996 • 16 citations

Concurrent Paclitaxel and Radiation Therapy for Solid Tumors

1996 • 14 citations

Paclitaxel (Taxol) for the treatment of lymphoma.

1997 • 13 citations

Enhancement of67Cu-2IT-BAT-LYM-1 therapy in mice with human burkitt's lymphoma (Raji) using interleukin-2

1997 • 12 citations

DecreasedC-MYCandBCL2Expression Correlates with Methylprednisolone-Mediated Inhibition of Raji Lymphoma Growth

1997 • 4 citations

Untitled

1997 • 4 citations